
TSE:SLF
This summary was created by AI, based on 12 opinions in the last 12 months.
Sun Life Financial Inc (SLF) is presently facing a challenging landscape, with mixed reviews from experts highlighting both the strengths and weaknesses of the company. Some analysts praise its strong management and growth potential in Asia, particularly in asset management, whereas others express concerns regarding its performance in the U.S. dental market and overall growth, particularly as compared to peers like Manulife Financial Corporation (MFC). Despite trading at a lower P/E ratio compared to Canadian banks, some experts argue that the stock's current valuation isn't compelling given the subdued growth prospects. However, SLF is recognized for its consistent dividend growth and stable earnings, and the recent share repurchases are seen as a positive move. Analysts are divided, with some asserting a long-term bullish outlook while others remain cautious pending macroeconomic or company-specific catalysts.
(A Top Pick March 20/12. Up 32.03%.) He had bought this as his anti-bond holding. Lifecos do much better in general when interest rates are high or if they are rising and he expects interest rates to continue to rise in the bond market. Also they are a major factor in the money management business through Mass Financial in the US and that subsidiary is doing gangbusters.
Lifecos have had quite a run over the last little while. They are a proxy for investors for interest rates going up and equity markets doing well. From a purely operational perspective, he feels they are probably ahead of themselves but they do benefit on the assumption side from interest rates plus their ability to reinvest. They all have asset management operations.
(Wrestling with the question as to whether he should take profits.) Thinks it is a little ahead of itself but if they manage to beat earnings targets it should be okay. One thing that seems to be supporting this stock has been the dividend yield. If you have a big position in this and have made a profit, he would recommend considering taking some off the table.
All lifecos were trading lower than BV, which is a pretty good sign for a value investor. Ranks very high in his Mark model. Have to start growing their BV now. Really tapered off their exposure to equities. Equities have done extremely well in the last 6 months but they’re not going to get the same bang for their buck as they once did. We now need interest rates to rise. Would prefer it at around $27.
Has had a decent run, partially because they dumped some things like getting out of the US annuity business. Also, took over a Malaysian life insurance company, which is a faster growth area. Decent dividend. (See Top Picks.)